Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain
- PMID: 994022
Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain
Abstract
Several compounds of relatively rigid molecular structure have been found to exert strong blockade of monoamine uptake by synaptosomal preparations of rat corpus striatum (dopamine and serotonin) and hypothalamus (norepinephrine). These include CP-24,441 (1R, 4S-N-methyl-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine), EXP-561 (4-phenylbicyclo[2.2.2]octan-1-amine), nomifensine and nefopam. The well-defined molecular geometry of the potent inhibitor EXP-561 is a fundamental structural/conformational requirement for uptake blocking activity for the large family of phenylbutylamine- and phenoxypropylamine-related inhibitors. The tubular configuration of EXP-561 may be the most appropriate for blocking serotonin uptake. The requisite conformation for blocking dopamine uptake appears to be defined by the combination resulting from superimposition of the CP-24,441 and nomifensine structures. The conformation defined by the combination resulting from superimposition of the CP-24-441 and desipramine structures is apparently optimal for blocking norepinephrine uptake. The conformational requirements for diphenylpropylamine-related uptake blockers may be defined by the rigid compound CP-39,332 (N-methyl-4-phenyl-1,2,3,4-tetrahydro-2-naphthylamine). The actual potency of any given inhibitor is probably modulated by additional structural and stereochemical factors.
Similar articles
-
A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.J Pharmacol Exp Ther. 1975 Jun;193(3):804-11. J Pharmacol Exp Ther. 1975. PMID: 1151730
-
7,N,N-Trimethyltryptamine: a selective inhibitor of synaptosomal serotonin uptake.Res Commun Chem Pathol Pharmacol. 1978 Jan;19(1):161-4. Res Commun Chem Pathol Pharmacol. 1978. PMID: 625585
-
Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.J Pharmacol Exp Ther. 1972 Mar;180(3):523-30. J Pharmacol Exp Ther. 1972. PMID: 5012779 No abstract available.
-
A review of the effects of repeated administration of selected phenylethylamines.Drug Alcohol Depend. 1986 Jun;17(2-3):143-50. doi: 10.1016/0376-8716(86)90005-0. Drug Alcohol Depend. 1986. PMID: 3017670 Review.
-
Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of neurodegenerative brain disorders?Adv Exp Med Biol. 2001;500:373-96. doi: 10.1007/978-1-4615-0667-6_61. Adv Exp Med Biol. 2001. PMID: 11764972 Review. No abstract available.
Cited by
-
Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.Neuropharmacology. 2014 Jan;76 Pt B(0 0):460-78. doi: 10.1016/j.neuropharm.2013.06.030. Epub 2013 Jul 11. Neuropharmacology. 2014. PMID: 23850573 Free PMC article. Review.
-
Oxidative stress biomarkers in some rat brain structures and peripheral organs underwent cocaine.Neurotox Res. 2013 Jan;23(1):92-102. doi: 10.1007/s12640-012-9335-6. Epub 2012 Jul 12. Neurotox Res. 2013. PMID: 22791409 Free PMC article.
-
Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat.Psychopharmacology (Berl). 1991;104(2):177-80. doi: 10.1007/BF02244175. Psychopharmacology (Berl). 1991. PMID: 1831559
-
Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.J Neurosci. 2001 Apr 15;21(8):2799-807. doi: 10.1523/JNEUROSCI.21-08-02799.2001. J Neurosci. 2001. PMID: 11306632 Free PMC article.
-
Self-administration of D1 receptor agonists by squirrel monkeys.Psychopharmacology (Berl). 1996 May;125(2):97-104. doi: 10.1007/BF02249407. Psychopharmacology (Berl). 1996. PMID: 8783382
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous